MANILA – The Presidential Communications Operations Office-Office of the Global Media and Public Affairs (PCOO-OGMPA) is releasing its third episode of “The VAXplainer,” which focuses on the efficacy of the Sinovac Biotech’s CoronaVac vaccines.
“This episode will provide components and specifics of the CoronaVac as a safe and effective vaccine for our medical front-liners and fellow Filipinos against Covid-19 as cited by our medical and health experts,” PCOO Secretary Martin M. Andanar said in a news release on Wednesday.
Andanar said the episode of ‘The VAXplainer’ gives deeper insights and ideas to the public to help them understand everything about CoronaVac. The PCOO-OGMPA will also produce explainer content videos for AstraZeneca and other vaccines to be soon available in the country.
This episode of “The VAXplainer” also features interviews with two Filipino experts on epidemiology and public health.
Dr. Maria Consorcia “Conky” Lim-Quizon, a member of the National Immunization Technical Advisory Group (NITAG), said the Covid-19 vaccine is safe and effective for medical professionals who are at the frontlines since the start of the pandemic in March last year.
On the other hand, Dr. Edsel Maurice Salvana, Director of Institute of Molecular Biology and Biotechnology – UP Manila and a member of the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) Technical Working Group on Covid-19 Variants, cited that the Covid-19 vaccine is modified from the original SARS outbreak 17 years ago.
“These vaccines have been in development for the last 17 years. They just swap out ‘yung SARS to SARS-COV-2. The science is there naman to be seen,” Salvana said during an interview.
Food and Drug Administration (FDA) Director-General Eric Domingo explained the emergency use authorization (EUA) was granted to Sinovac on Feb. 21, 2021 after intensive and meticulous assessment on the Chinese-made vaccine.
On Feb. 28, 2021, President Rodrigo Roa Duterte witnessed the arrival of the first 600,000 doses of CoronaVac vaccine as part of China’s commitment to supporting the national vaccination rollout.
On Wednesday, another 400,000 doses of CoronaVax vaccine arrived in the country, bringing to 1 million the total Sinovac jabs donated by the Chinese government.
Sinovac’s CoronaVac is the third Covid-19 vaccine brand granted an emergency use authorization by the country’s Food and Drug Administration (FDA), after Pfizer-BioNTech and AstraZeneca. EUA was also recently granted to Gamaleya’s Sputnik V, the first Russian-made vaccine against Covid-19.
The “VAXplainer” will be aired on PTV and IBC-13. It will also be livestreamed on the PCOO, National Task Force Against Covid-19, and Department of Health’s Facebook pages, as well as other government-affiliated social media pages. (PNA)